Atara Biotherapeutics announced that the Marketing Authorization Application (MAA) for tabelecleucel (tab-cel®) has been fully validated by the European Medicines Agency (EMA).
Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging.
Expertscape rankings recognize Richard Schulick, MD, and Marco Del Chiaro, MD, among the top 0.1% of scholars worldwide.
TBX-2400 is expected to improve engraftment and reconstitution of immune system for patients receiving Hematopoietic Stem Cell Transplants.
Amie Krause, Senior Vice President and Chief People Officer, and Kristin Yarema, Chief Commercial Officer, of Atara Biotherapeutics, discuss women in leadership positions in pharma and the effects of a gender diverse company.
Many studies have shown that companies with diverse leadership and innovation teams are the most successful and profitable.
Faculty within the University of Colorado system received a total of $1.45 billion in sponsored research funding and research gifts this year…
The Denver-Boulder market ranks among the top 10 bioscience markets in the U.S and Canada, according to a new report…
The Gates Biomanufacturing Facility announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells.
Aurora, Colo.-based Foresight Diagnostics, which was co-founded in 2020 by Jake Chabon, PhD, Max Diehn, MD, PhD, Ash Alizadeh, MD, PhD, and David Kurtz, MD PhD, has developed a new liquid biopsy test that can identify the earliest hint of cancer recurrence.